Premium Supplement NMN KIWAMI Made in Japan with FDA Compliance Seeks Strategic U.S. Distribution Partnerships
Clinically validated with confirmed telomere lengthening and used in Japanese medical institutions and IV therapies, this product supports distributor wellness portfolios with a 95% repeat rate.
Japan, 3rd Mar 2026 – Asa Pharmaceutical Co., Ltd. (Headquarters: Minato Ward, Tokyo; President and CEO: Tomoko Iwase), a manufacturer and distributor of health supplements, announced that effective Monday, January 26, 2026, it will significantly strengthen its supply structure for the Japanese-made NMN supplement NMN KIWAMI in the North American market and will officially begin accepting applications for local sales distributors.
NMN KIWAMI is sold exclusively through medical institutions in Japan due to its high quality and is also used as a raw material for NMN intravenous therapy, positioning...
